Navigation Links
Floating spores kill malaria mosquito larvae
Date:2/20/2011

There are over 200 million cases of malaria each year and, according to the World Health Organisation, in 2009 malaria was responsible for 781,000 deaths worldwide. Malaria is spread by mosquitoes which breed in open water and spend much of their larval stage feeding on fungi and microorganisms at the water surface. New research published in BioMed Central's open access journal Parasites and Vectors presents a method of dispersing pathogenic fungi as a means of preventing the spread of malaria.

The parasite (genus Plasmodium), which causes malaria, is transmitted to humans with mosquito saliva during a bite, where it invades the liver and red blood cells causing fever. Once infected, it can be difficult for a human host to recover because some species of Plasmodium are able to lie dormant and evade antimalarial drugs. These parasites are also becoming resistant to the antimalarials taken to prevent infection. An alternative way of reducing the risk of malaria infection is to kill the mosquitoes. The fungi, M. anisopliae and B. bassiana, cause muscardine disease in mosquito larvae, leading to their death before they can pupate and develop into the adult form.

Tullu Bukhari and colleagues from the Laboratory of Entomology, Wageningen University, The Netherlands, have used a synthetic oil (ShellSol T) as a means of dispersing fungal spores over the surface of water. The oil-spore preparation is easy to mix and use of the oil improved the dispersal of spores across the water. This simple formulation increased both the persistence and effectiveness of spores, killing up to 50% more larvae than untreated spores and reducing pupation levels to less than 20% at a test site in Kenya.

Speaking about the research Tullu Bukhari said, "these fungi provide an effective means of controlling malaria mosquitoes. Both spores and the oil have minimal risk to fish and aquatic organisms and so are also environmentally safe."


'/>"/>

Contact: Dr. Hilary Glover
hilary.glover@biomedcentral.com
44-203-192-2370
BioMed Central
Source:Eurekalert

Page: 1

Related biology news :

1. Study shows stability and utility of floating wind turbines
2. Fungal spores travel farther by surfing their own wind
3. C. difficile spores spread superbug
4. In many fungi, reproductive spores are remarkably aerodynamic
5. University of South Florida and Draper team to create advanced devices for testing malaria drugs
6. Malaria medication may help against 1 type of frontotemporal dementia
7. Malaria modeling and control focus of workshop
8. Malaria-infected cells stiffen, block blood flow
9. New study examines immunity in emerging species of a major mosquito carrer of malaria
10. Researchers link cerebral malaria to epilepsy, behavior disorders
11. UC Riverside cell biologist to investigate how malaria parasite multiplies in red blood cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
(Date:2/9/2017)... LONDON , Feb. 9, 2017 The ... in-depth analysis of the biomass boiler market globally in ... sales of biomass boilers. The market for biomass boilers ... product type, end-user, application, and country/region. The market based ... agriculture & forest residues, biogas & energy crops, urban ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)... MENLO PARK, Calif., March 23, 2017  BioPharmX ... developing products for the dermatology market, today reported ... Jan. 31, 2017, and will provide an update ... from the year. "We are pleased ... productive year for BioPharmX," said President Anja Krammer. ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/23/2017)... -- In today,s pre-market research, Stock-Callers.com takes ... industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals Inc. ... Regulus Therapeutics Inc. (NASDAQ: RGLS ). On ... rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more about ... ...
Breaking Biology Technology: